BCM
RXII

Buckhead Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Buckhead Capital Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,640
Closed -$4K – 181
2016
Q3 		$4K Hold
10,640
– – ﹤0.01% 175
2016
Q2 		$5K Hold
10,640
– – ﹤0.01% 179
2016
Q1 		$14K Hold
10,640
– – ﹤0.01% 181
2015
Q4 		$16K Hold
10,640
– – ﹤0.01% 193
2015
Q3 		$17K Hold
10,640
– – ﹤0.01% 191
2015
Q2 		$18K Sell
10,640
-4,890
-31% -$8.27K ﹤0.01% 196
2015
Q1 		$22K Buy
15,530
+3,900
+34% +$5.53K ﹤0.01% 190
2014
Q4 		$18K Hold
11,630
– – ﹤0.01% 198
2014
Q3 		$24K Buy
+11,630
New +$24K ﹤0.01% 198

Buckhead Capital Management's RXII Position: Q4 2016 in Review

Buckhead Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 10,640 shares — an estimated $4K sold.

Buckhead Capital Management first reported a position in RXII in Q3 2014 and held it in 9 quarters. The position peaked at $24K in Q3 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Buckhead Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Buckhead Capital Management sold 10,640 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Buckhead Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q3 2014 and held it in 9 quarters.
  • Buckhead Capital Management's GALENA BIOPHARMA INC COM position peaked at $24K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Buckhead Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.